We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BAX market cap is 15.06B. The company's latest EPS is USD 5.2018 and P/E is 5.67.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.71B | 3.9B | 3.6B | 3.81B | 484M |
| Operating Income | -205M | 566M | 187M | -192M | 421M |
| Net Income | 2.35B | 483M | 37M | -314M | 439M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 11.5B | 11.69B | 12.79B | 15.11B | 14.84B |
| Operating Income | 1.77B | 1.5B | 1.71B | -1.93B | 397M |
| Net Income | 1B | 980M | 1.28B | -2.43B | 2.66B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 30.66B | 28.28B | 27.79B | 26.31B | 0 |
| Total Liabilities | 22.49B | 19.81B | 19.55B | 18.6B | 0 |
| Total Equity | 8.17B | 8.47B | 8.24B | 7.71B | 0 |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 18.19B | 20.02B | 33.52B | 28.29B | 28.28B |
| Total Liabilities | 10.28B | 11.29B | 24.4B | 22.39B | 19.81B |
| Total Equity | 7.91B | 8.73B | 9.12B | 5.9B | 8.47B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.2B | 1.73B | 495M | 278M | N/A |
| Investing | 3.44B | 3.21B | -166M | -257M | N/A |
| Financing | -554M | -3.49B | -140M | -1.08B | N/A |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 2.1B | 1.87B | 2.22B | 1.21B | 1.73B |
| Investing | -1.1B | -1.18B | -11.2B | -931M | 3.21B |
| Financing | 498M | -345M | 8.25B | -1.44B | -3.49B |
| Market Cap | 15.06B |
| Price to Earnings Ratio | 5.67 |
| Price to Sales Ratio | 1.01 |
| Price to Cash Ratio | 4.72 |
| Price to Book Ratio | 1.78 |
| Dividend Yield | 2.31% |
| Shares Outstanding | 510.59M |
| Average Volume (1 week) | 5.74M |
| Average Volume (1 Month) | 4.59M |
| 52 Week Change | -23.79% |
| 52 Week High | 44.005 |
| 52 Week Low | 28.6152 |
| Spread (Intraday) | 0.62 (2.08%) |
| Company Name | Baxter International Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.baxter.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
